Company Profile
Seagen Stock Price, News & Analysis
- Ticker:
- SGEN
- Exchange:
- NASDAQ
- Sector:
- Antibody Drugs, ADCs
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for SGEN.
Company overview
Business overview
Seagen was a biotechnology company focused on antibody-drug conjugates and oncology before being acquired by Pfizer. Its identity was tied to cancer therapeutics and the broader validation of ADC technology.
Geographic Base and Sector Classification
Seagen was headquartered in the United States and listed on NASDAQ before its acquisition. It sat in oncology biotechnology with a strong U.S. commercial and development presence.
Business Model Characteristics
The business depended on oncology product sales, ADC innovation, and the ability to expand the reach of its platform through development and partnership activity. Investors focused on clinical data, label expansion, and the strategic value of its ADC franchise.
Position Within the Biotechnology Landscape
Seagen was one of the most important ADC-focused biotech companies of its time. It occupied a high-catalyst position because oncology readouts and platform validation directly influenced the stock.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Seagen do?
Seagen was a biotechnology company focused on antibody-drug conjugates and oncology before being acquired by Pfizer. Its identity was tied to cancer therapeutics and the broader validation of ADC technology.
On which exchange is SGEN stock listed?
Seagen (SGEN) is associated with NASDAQ, United States, Antibody Drugs, ADCs.
What is Seagen?
Seagen was a biotechnology company focused on antibody-drug conjugates and oncology before being acquired by Pfizer.
Which conditions is Seagen targeting with Seagen?
Seagen is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
What is Pfizer?
Seagen was a biotechnology company focused on antibody-drug conjugates and oncology before being acquired by Pfizer.